Metraipolis › archive › dc_304be4f992f7

Melatonin-Mediated Nrf2 Activation as a Potential Therapeutic Strategy in Mutation-Driven Neurodegenerative Diseases — Europe PMC PMID:41154499

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41154499
DOI
10.3390/antiox14101190
License (as archived)
solo-consultazione
Archived
2026-11-09T17:40:56.660Z
SHA-256 of the archived text
2fcc99ad1b2bf8d0d426b0692c1d29924a2d6bda49d4170198b10ed4580eacd0
Stable URL of this page
https://metraipolis.com/documento/dc_304be4f992f7

How to cite

Melatonin-Mediated Nrf2 Activation as a Potential Therapeutic Strategy in Mutation-Driven Neurodegenerative Diseases — Europe PMC PMID:41154499 — Europe PMC (en), https://europepmc.org/article/MED/41154499 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_304be4f992f7 (Metraipolis archive dc_304be4f992f7, sha256 2fcc99ad1b2bf8d0d426b0692c1d29924a2d6bda49d4170198b10ed4580eacd0)
BibTeX
@misc{dc304be4f992f7,
  title = {Melatonin-Mediated Nrf2 Activation as a Potential Therapeutic Strategy in Mutation-Driven Neurodegenerative Diseases — Europe PMC PMID:41154499},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41154499},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_304be4f992f7; sha256 2fcc99ad1b2bf8d0d426b0692c1d29924a2d6bda49d4170198b10ed4580eacd0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41154499. Agents can read the archived copy with the MCP tool read_document.